SecBot SecBot
6-K ·Filed Sep 3, 2026

GLMD

Galmed Pharmaceuticals Ltd.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001493152-26-041357
Notable filing: 6-K
Actionable Insight • Neutral

This filing contains no new financial data or strategic developments. Monitor future filings for operational updates or pipeline progress.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d ⚠ clustered
GLMD ▲ +19.33% at T+5d
NEUTRAL call +19.33% · α vs SPY +20.54% · entry $3.88 → $4.63
Next anchor: T+20d due 25d ago
Entry = T+0 close
Sep 3, 2026
via day close
T+1d
-1.42%
call -1.42% · α -0.87%
$3.83
settled 8w ago
T+5d
+19.33%
call +19.33% · α +20.54%
$4.63
settled 7w ago
T+20d
Pending
due 25d ago
T+60d
Pending
in 5w

Price Chart

Loading chart...

Executive Summary

Galmed Pharmaceuticals held its Annual General Meeting on September 3, 2026, and all proposals were approved by shareholders with the requisite majority. This is a routine governance filing with no material financial or operational impact.

Key Facts

  • Annual General Meeting held on September 3, 2026.
  • All proposals described in the proxy statement were approved by shareholders.
  • The 6-K is incorporated by reference into existing S-8 and F-3 registration statements.

Financial Impact

Not specified

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001493152-26-041357
Document: 0001493152-26-041357-index-headers.html0001493152-26-041357
Document: 0001493152-26-041357-index.html0001493152-26-041357
Document: 0001493152-26-041357.txt0001493152-26-041357
15 reports for GLMD
Performance horizon
57% Hit rate @ T+5 4 of 7 directional calls Went positive at some point 6 of 8 best @ T+5▲ +31.26%Jun 8, 2026
Filters
Rows
Reports for GLMD — sortable, filterable
TypeNow
Sep 9, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$4.63 $3.63▼ −21.71%▼ −21.37%—
Sep 4, 2026
7w ago
EFFECT
BEARISH ★ 5/10
$3.88 $4.63▼ −19.33%▼ −20.54%—
Sep 3, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$3.88 $4.63▲ +19.33%▲ +20.54%—
Sep 2, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$3.92 $4.63▲ +18.11%▲ +19.26%—
Aug 19, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$4.77 $4.33▼ −9.22%▼ −8.84%—
Aug 17, 2026
10w ago
6-K
BULLISH ★ 6/10
$0.5134awaiting T+5——
Jul 28, 2026
12w ago
6-K
NEUTRAL ★ 4/10
$0.5340 $0.5754▲ +7.75%▲ +3.64%—
Jul 16, 2026
14w ago
6-K
BULLISH ★ 6/10
$0.5501 $0.5530▲ +0.53%▲ +2.20%—
Jun 22, 2026
18w ago
6-K
BULLISH ★ 7/10
$0.5641 $0.5709▲ +1.21%▲ +1.66%—
Jun 8, 2026
20w ago
6-K
BULLISH ★ 7/10
$0.4693 $0.6160▲ +31.26%▲ +29.15%—
Showing 10 of 15

US Market Status

Market Closed — Opens Wed (12h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 3, 2026